Vir Biotechnology (VIR) Total Current Liabilities (2018 - 2026)

Vir Biotechnology's Total Current Liabilities history runs 9 years deep, the most recent figure standing at $73.6 million for Q1 2026.

• In Q1 2026, Total Current Liabilities fell 46.42% year-over-year to $73.6 million; the TTM figure through Mar 2026 stood at $73.6 million (down 46.42% YoY), while the FY2025 annual figure was $92.8 million, down 22.44% from the prior year.
• Total Current Liabilities came in at $73.6 million for Q1 2026 at Vir Biotechnology, down from $92.8 million in the prior quarter.
• In the past five years, Total Current Liabilities ranged from a high of $702.4 million in Q1 2022 to a low of $73.6 million in Q1 2026.
• A 5-year average of $233.1 million and a median of $137.3 million in 2025 frame the typical range for Total Current Liabilities.
• Across the five-year window, Total Current Liabilities jumped 227.25% in 2022 and sank 80.62% in 2024, its largest moves.
• Vir Biotechnology's Total Current Liabilities stood at $511.0 million in 2022, then tumbled by 65.68% to $175.4 million in 2023, then slumped by 31.78% to $119.7 million in 2024, then fell by 22.44% to $92.8 million in 2025, then retreated by 20.75% to $73.6 million in 2026.
• According to Business Quant data, Total Current Liabilities over the past three periods registered $73.6 million, $92.8 million, and $75.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison